A) Inflammability B) Toxicity C) Corrosiveness D) Biocompatibility
A) To block cell growth B) To provide a structure for cells to grow and organize C) To prevent regeneration D) To induce inflammation
A) Biodegradability B) Thermal conductivity C) Fatigue resistance D) Chemical stability
A) Biocompatibility B) High cost C) Corrosion D) Heavy weight
A) Decrease biocompatibility B) Reduce mechanical strength C) Increase toxicity D) Enhanced surface interactions and properties
A) Silicone rubber B) Hydroxyapatite C) Polyethylene D) PMMA
A) Red blood cells B) Keratinocytes C) Macrophages D) Fibroblasts
A) To prevent infections B) To accelerate degradation C) To increase toxicity D) To promote inflammation
A) Quantum mechanics B) Astrophysics C) Biomaterials science or biomaterials engineering D) Marine biology
A) Biomaterials cannot be used in medical applications B) There is no difference between them C) Biomaterials are engineered, while biological materials are naturally produced D) Biological materials are always synthetic
A) Metallic components, polymers, ceramics, or composite materials B) Exclusively organic compounds C) Pure water-based solutions D) Only natural fibers
A) Using only historical data without new testing B) By computational routines predicting molecular effects based on limited in vitro experimentation C) Through random trial and error methods D) Exclusively through animal testing
A) The random distribution of particles in a solution. B) A process requiring mechanical manipulation to form structures. C) An assembly method that uses magnetic fields. D) The spontaneous aggregation of particles without external forces.
A) The temperature at which assembly occurs. B) The external forces applied to the system. C) The chemical composition of particles. D) The spatial scale of the unit cell (lattice parameter).
A) Self-organization. B) External guidance and control. C) Random particle distribution. D) Chemical bonding between particles.
A) 3 nm. B) 70 to 100 nm. C) 1.5 nm. D) 60 nm.
A) 70/30. B) 80/20. C) About 60/40. D) 50/50.
A) On the surface of tropocollagen molecules. B) At the gaps between collagen fibrils. C) Within the mineral phase only. D) Randomly throughout the matrix.
A) "Bricks" with dimensions of 0.5. B) 60 nm diameter canals. C) 20 to 30 nm layers. D) 1 μm diameter rods.
A) Calcium carbonate. B) Hydroxyapatite. C) Chitin. D) Collagen.
A) A helical pattern. B) An amorphous structure. C) A cubic pattern. D) A random distribution.
A) 60 nm. B) 20 to 30 nm. C) 70 to 100 nm. D) 1 μm.
A) ISO 10993 B) ISO 14001 C) ISO 27001 D) ISO 9001
A) Amino acids B) Nucleotides C) Fatty acids D) Sugars
A) Dental filling material B) Bone graft substitute C) Heart valve coating D) Artificial skin scaffold
A) Calcium sulfate B) Polyethylene terephthalate C) Pyrolytic carbon D) Stainless steel
A) Synthetic polymers B) Plant fibers C) Metal wires D) Animal skin
A) 14 different configurations B) 10 different configurations C) 20 different configurations D) 5 different configurations
A) Kevlar B) Spandex C) Dacron D) Nylon
A) Foreign body response (FBR) B) Inflammatory reaction C) Healing process D) Immune response
A) Molecular level B) Microstructure level C) Ultra-structure level D) Sub atomic level
A) 49% B) 25% C) 75% D) 60%
A) Mechanically strong B) Chemically reactive C) Electrically conductive D) Non-biodegradable
A) 20 to 30 nm. B) 3 nm. C) 1 μm. D) 60 nm.
A) 70 to 100 nm. B) Approximately 60 nm. C) 1.5 nm. D) 3 mm.
A) Biocompatibility B) Biomimetics C) Biofabrication D) Biodegradation
A) Later 1960s B) 2000s C) 1980s D) Early 1950s
A) Bone strengthening B) Tissue growth stimulation C) Drug delivery D) Wound closure
A) Healing phase B) Resolution phase C) Acute phase D) Chronic phase
A) Brittle B) Biocompatible C) Toxic D) Non-degradable
A) Size B) Elasticity C) Shape D) Alignment
A) Polymers B) Silica C) Polyetheretherketone (PEEK) D) Liposomes
A) Proteins B) DNA C) Starch D) Cellulose
A) Neutrophils B) Macrophages C) Eosinophils D) Lymphocytes
A) Biocompatibility B) Foreign body response C) Graft-versus-host disease D) Acute inflammation only
A) Joint replacements B) Dental implants C) Skin repair devices D) Contact lenses
A) No structures are isolated B) The implant C) Only the damaged tissue D) Immune cells
A) Starch B) DNA C) Silk D) Cellulose
A) Toxic B) Non-biodegradable C) Inert D) Biodegradable
A) Young's Modulus B) Flexural rigidity C) Tensile strength D) Ductility
A) Cyclic olefin polymer (COP) B) Polyetherimide (PEI) C) Polycarbonate (PC) D) Polypropylene (PP)
A) Avoid any interaction with the immune system B) Suppress the immune response entirely C) Direct the immune response rather than circumvent it D) Elicit a strong immune reaction
A) Elasticity B) Toughness C) Compressive strength D) Flexural rigidity
A) Ivory B) Stainless steel C) Aluminum D) Ceramic
A) Mass Spectrometry B) X-ray Diffraction C) Nuclear Magnetic Resonance D) Scanning Electron Microscopy
A) Point defects B) Macrostructure C) Edge dislocation D) Line defects |